RENAISSANCE TECHNOLOGIES LLC

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 1037389 NEW YORK, NY

Position in BRNS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$85,919

-$14,251 QoQ

Shares Held

151,000

+5.5% QoQ

Ownership

0.370%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. BRNS ranks #291 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$85,919	151,000	+5.5%	Shares	Sole	2026-05-14
2025-12-31	$100,170	143,100	+115.8%	Shares	Sole	2026-02-12
2025-09-30	$82,875	66,300	+82.6%	Shares	Sole	2025-11-13
2025-06-30	$33,759	36,300	+1.7%	Shares	Sole	2025-08-13
2025-03-31	$34,736	35,700	+1.7%	Shares	Sole	2025-05-14
2024-12-31	$42,400	35,100	+25.8%	Shares	Sole	2025-02-13
2024-09-30	$33,201	27,900	+11.2%	Shares	Sole	2024-11-13
2024-06-30	$35,140	25,100	-9.4%	Shares	Sole	2024-08-09
2024-03-31	$65,926	27,700	-6.7%	Shares	Sole	2024-05-13
2023-12-31	$109,589	29,699	+38.8%	Shares	Sole	2024-02-13
2023-09-30	$66,126	21,400	-37.1%	Shares	Sole	2023-11-14
2023-06-30	$70,040	34,000	+198.2%	Shares	Sole	2023-08-11
2023-03-31	$25,536	11,400	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.